Dr. Mark Kronenfeld, M.D

NPI: 1306084389
Total Payments
$2.5M
2024 Payments
$277,850
Companies
5
Transactions
210

Payment Breakdown by Category

Other$2.4M (95.6%)
Consulting$92,607 (3.7%)
Food & Beverage$10,155 (0.4%)
Travel$8,875 (0.4%)
Gifts$464.41 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Current or prospective ownership or investment interest $1.4M 18 54.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $606,381 22 24.0%
Honoraria $252,258 11 10.0%
Compensation for serving as faculty or as a speaker for a medical education program $185,873 2 7.4%
Consulting Fee $92,607 5 3.7%
Food and Beverage $10,155 112 0.4%
Travel and Lodging $8,875 31 0.4%
Acquisitions $1,235 1 0.0%
Gift $464.41 8 0.0%

Top Paying Companies

Company Total Records Latest Year
Pacira Pharmaceuticals Incorporated $2.5M 200 $0 (2024)
Topera, Inc. $4,198 5 $0 (2021)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $46.66 2 $0 (2018)
Mallinckrodt LLC $27.14 2 $0 (2018)
Abbott Laboratories $25.39 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $277,850 20 Pacira Pharmaceuticals Incorporated ($277,850)
2023 $352,339 28 Pacira Pharmaceuticals Incorporated ($352,339)
2022 $350,786 16 Pacira Pharmaceuticals Incorporated ($350,786)
2021 $331,634 17 Pacira Pharmaceuticals Incorporated ($330,400)
2020 $442,036 7 Pacira Pharmaceuticals Incorporated ($441,613)
2019 $319,610 36 Pacira Pharmaceuticals Incorporated ($319,042)
2018 $177,672 37 Pacira Pharmaceuticals Incorporated ($176,862)
2017 $273,928 49 Pacira Pharmaceuticals Incorporated ($272,667)

All Payment Transactions

210 individual payment records from CMS Open Payments — Page 3 of 9

Date Company Product Nature Form Amount Type
10/05/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Honoraria Cash or cash equivalent $24,500.00 General
Category: Pain Management
09/23/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $74.87 General
Category: Pain Management
09/22/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $90.04 General
Category: Pain Management
09/22/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $82.92 General
Category: Pain Management
09/21/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Travel and Lodging In-kind items and services $669.76 General
Category: Pain Management
09/21/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $414.90 General
Category: Pain Management
07/06/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Honoraria Cash or cash equivalent $24,500.00 General
Category: Pain Management
06/09/2022 Pacira Pharmaceuticals Incorporated Current or prospective ownership or investment interest In-kind items and services $195,023.59 General
06/03/2022 Pacira Pharmaceuticals Incorporated Current or prospective ownership or investment interest In-kind items and services $68,554.46 General
04/06/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Honoraria Cash or cash equivalent $18,508.00 General
Category: Pain Management
03/02/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $72.99 General
Category: Pain Management
03/01/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $225.78 General
Category: Pain Management
03/01/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Travel and Lodging In-kind items and services $169.12 General
Category: Pain Management
01/06/2022 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Honoraria Cash or cash equivalent $17,750.00 General
Category: Pain Management
12/08/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $22.09 General
Category: Pain Management
12/08/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $20.52 General
Category: Pain Management
12/07/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $241.76 General
Category: Pain Management
10/06/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $17,750.00 General
Category: Pain Management
09/23/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $69.56 General
Category: Pain Management
09/22/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $161.08 General
Category: Pain Management
09/20/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Travel and Lodging In-kind items and services $123.72 General
Category: Pain Management
07/07/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $17,750.00 General
Category: Pain Management
06/09/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Current or prospective ownership or investment interest In-kind items and services $179,997.13 General
Category: Pain Management
06/09/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $46.92 General
Category: Pain Management
06/09/2021 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $29.05 General
Category: Pain Management

About Dr. Mark Kronenfeld, M.D

Dr. Mark Kronenfeld, M.D is a Anesthesiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1306084389.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Kronenfeld, M.D has received a total of $2.5M in payments from pharmaceutical and medical device companies, with $277,850 received in 2024. These payments were reported across 210 transactions from 5 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($1.4M).

Practice Information

  • Specialty Anesthesiology
  • Location Brooklyn, NY
  • Active Since 01/28/2009
  • Last Updated 01/28/2009
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1306084389

Products in Payments

  • EXPAREL (Drug) $1.2M
  • Exparel (Drug) $587,949
  • Iovera (Device) $286.99
  • LifeVest (Device) $46.66
  • OFIRMEV (Drug) $27.14
  • Circulatory Support (Device) $25.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anesthesiology Doctors in Brooklyn